Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26979
Title: | Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey. | Austin Authors: | Yeung, Emily;Bello, A K;Levin, Adeera;Lunney, Meaghan;Osman, Mohamed A;Ye, Feng;Ashuntantang, Gloria;Bellorin-Font, Ezequiel;Benghanem Gharbi, Mohammed;Davison, Sara;Ghnaimat, Mohammad;Harden, Paul;Jha, Vivekanand;Kalantar-Zadeh, Kamyar;Kerr, Peter;Klarenbach, Scott;Kovesdy, Csaba;Luyckx, Valerie;Neuen, Brendon;O'Donoghue, Donal;Ossareh, Shahrzad;Perl, Jeffrey;Ur Rashid, Harun;Rondeau, Eric;See, Emily J ;Saad, Syed;Sola, Laura;Tchokhonelidze, Irma;Tesar, Vladimir;Tungsanga, Kriang;Turan Kazancioglu, Rumeyza;Wang, Angela Yee-Moon;Wiebe, Natasha;Yang, Chih-Wei;Zemchenkov, Alexander;Zhao, Minhui;Jager, Kitty J;Caskey, Fergus;Perkovic, Vlado;Jindal, Kailash;Okpechi, Ikechi G;Tonelli, Marcello;Feehally, John;Harris, David Ch;Johnson, David | Affiliation: | Division of Nephrology, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada Monash Health, Clayton, Victoria, Australia Population Health Sciences, University of Bristol, Bristol, UK Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, UK Salford Royal Hospitals NHS Trust, Salford, UK Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri, USA Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California, USA Nephrology, Memphis VA Medical Center, Memphis, Tennessee, USA Department of Nephrology, Monash Medical Centre Clayton, Clayton, Victoria, Australia Department of Medicine, Monash University, Clayton, Victoria, Australia The George Institute for Global Health, Newtown, New South Wales, Australia Intensive Care Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia Centre for Kidney Disease Research, The University of Queensland, Saint Lucia, Queensland, Australia Metro South Integrated Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Woolloongabba, Queensland, Australia Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Medicine, University of Alberta, Edmonton, Alberta, Canada Division of Nephrology and Immunology, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada Department of Medicine, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Intensive Care Nephrology and Transplantation Department, Assistance Publique-Hopitaux de Paris, Paris, France George Institute for Global Health, New Dehli, India Department of Nephrology, St Michael's Hospital, Toronto, Ontario, Canada Department of Medicine, King Chulalong Memorial Hospital, Bangkok, Thailand Bhumirajanagarindra Kidney Institute, Bangkok, Thailand Oxford Kidney Unit, Oxford University Hospitals NHS Trust, Oxford, UK Faculty of Medicine and Biomedical Sciences, University of Yaounde I Faculty of Medicine and Biomedical Sciences, Yaounde, Cameroon Urinary Tract Diseases Department, University of Hassan II Casablanca Faculty of Science Ain Chock, Casablanca, Morocco Department of Internal Medicine, The Specialty Hospital, Amman, Jordan Institute of Biomedical Ethics and the History of Medicine, University of Zurich Institute of Biomedical Ethics History of Medicine, Zurich, Switzerland Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia. Department of Nephrology, Charles University, Praha, Czech Republic Division of Nephrology, Bezmialem Vakif Universitesi, Istanbul, Turkey Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong Kidney Research Center, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Internal Disease and Nephrology, North-Western State Medical University named after I I Mechnikov, Sankt-Peterburg, Russia Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Medicine, University of Cape Town, Cape Town, South Africa |
Issue Date: | 9-Jul-2021 | Date: | 2021-07-09 | Publication information: | BMJ Open 2021; 11(7): e047245 | Abstract: | The Global Kidney Health Atlas (GKHA) is a multinational, cross-sectional survey designed to assess the current capacity for kidney care across all world regions. The 2017 GKHA involved 125 countries and identified significant gaps in oversight, funding and infrastructure to support care for patients with kidney disease, especially in lower-middle-income countries. Here, we report results from the survey for the second iteration of the GKHA conducted in 2018, which included specific questions about health financing and oversight of end-stage kidney disease (ESKD) care worldwide. A cross-sectional global survey. Key stakeholders from 182 countries were invited to participate. Of those, stakeholders from 160 countries participated and were included. Primary outcomes included cost of kidney replacement therapy (KRT), funding for dialysis and transplantation, funding for conservative kidney management, extent of universal health coverage, out-of-pocket costs for KRT, within-country variability in ESKD care delivery and oversight systems for ESKD care. Outcomes were determined from a combination of desk research and input from key stakeholders in participating countries. 160 countries (covering 98% of the world's population) responded to the survey. Economic factors were identified as the top barrier to optimal ESKD care in 99 countries (64%). Full public funding for KRT was more common than for conservative kidney management (43% vs 28%). Among countries that provided at least some public coverage for KRT, 75% covered all citizens. Within-country variation in ESKD care delivery was reported in 40% of countries. Oversight of ESKD care was present in all high-income countries but was absent in 13% of low-income, 3% of lower-middle-income, and 10% of upper-middle-income countries. Significant gaps and variability exist in the public funding and oversight of ESKD care in many countries, particularly for those in low-income and lower-middle-income countries. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26979 | DOI: | 10.1136/bmjopen-2020-047245 | ORCID: | 0000-0002-1244-1044 0000-0003-4954-0529 0000-0003-4513-6449 0000-0002-6545-9715 0000-0002-0846-3187 |
Journal: | BMJ Open | PubMed URL: | 34244267 | Type: | Journal Article | Subjects: | chronic renal failure dialysis end stage renal failure epidemiology health economics organisation of health services |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.